Leerink Swann Initiates Coverage on Livongo Health (NASDAQ:LVGO)
Equities research analysts at Leerink Swann began coverage on shares of Livongo Health (NASDAQ:LVGO) in a research note issued on Monday, The Fly reports. The firm set an “outperform” rating and a $50.00 price target on the stock. Leerink Swann’s target price would suggest a potential upside of 42.90% from the company’s current price.
Other analysts have also issued research reports about the stock. Piper Jaffray Companies started coverage on shares of Livongo Health in a report on Monday. They issued an “overweight” rating and a $40.00 price target for the company. Chardan Capital started coverage on shares of Livongo Health in a report on Friday, August 16th. They issued a “neutral” rating and a $40.00 price target for the company. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Livongo Health has a consensus rating of “Buy” and a consensus price target of $44.20.
Shares of Livongo Health stock opened at $34.99 on Monday. Livongo Health has a fifty-two week low of $31.60 and a fifty-two week high of $45.68.
About Livongo Health
Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.
Read More: What does a hold rating mean?
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.